Clinical Trial Results
Showing:
All studies
[change]
Condition: Arthritis
Location: Akron, Ohio
21 trials found
New Search
Exactech Shoulder Post Market Clinical Follow-up Study
RECRUITING
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
RECRUITING
A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis
RECRUITING
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
RECRUITING
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
RECRUITING
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
RECRUITING
Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis
RECRUITING
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
RECRUITING
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
RECRUITING
A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis
RECRUITING
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
RECRUITING
Z1 Hip System: Post-Market Clinical Follow Up Study
RECRUITING
A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis
RECRUITING
Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry
RECRUITING
Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).
RECRUITING
Persona Revision Knee System Outcomes
RECRUITING
RA-PRO PRAGMATIC TRIAL
RECRUITING
A Multicenter, Postmarket Surveillance Study of Subjects With the Canary canturioTM te Tibial Extension
RECRUITING
Preventing Injured Knees From osteoArthritis: Severity Outcomes
RECRUITING
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
RECRUITING
Improving Total Knee Arthroplasty Dissatisfaction Through a Personalized Approach Focusing on PROMs Phenotypes
RECRUITING